Trial Condition(s):
Scandinavian Mirena Insertion Nulliparous Trial.
14015
Not Available
Not Available
In this non-interventional study we investigate the nulliparous women individual evaluation of the insertion procedure of LNG-IUD and the follow-up period of 3 months post insertion.
- Nulliparous women Mirena insertion planned as contraceptive method
- Ongoing or suspected pregnancy; - Ongoing or recidivating genital infection; - Cervicitis; - Cervical dysplasia; - Malignancy in uterus or cervix; - Confirmed or suspected hormone sensitive neoplasia including breast cancer - Undiagnosed abnormal uterine bleeding; - Uterine anomaly including myoma if the cavity of the uterus is restricted; - Conditions that cause increased risk of infections; - Acute liver disease or liver tumour; - Allergy to the active substance or any component of the IUD
Locations | |
---|---|
Locations Investigative Site Many Locations, Sweden | Contact Us: E-mail: [email protected] Phone: Not Available |
Scandinavian Mirena Insertion Nulliparous Trial of an observational study.
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1